A probiotic fermented milk drink containing Lactobacillus casei strain shirota improves stool consistency of subjects with hard stools

International Journal of Probiotics and Prebiotics

Volumn 9, Issue 1-2, 2014, Pages 23-30

  Tilley, Linde ^a   Keppens, Katleen ^a   Kushiro, Akira ^b   Takada, Toshihiko ^b   Sakai, Takafumi ^b   Vaneechoutte, Mario ^c   Degeest, Bart ^d  

^a Groepspraktijk Heirnis (GP Practice)   (Belgium)

^b YAKULT CENTRAL INSTITUTE FOR MICROBIOLOGICAL RESEARCH   (Japan)

^c GHENT UNIVERSITY   (Belgium)

^d Yakult Belgium NV   (Belgium)

Author keywords

Constipation; Improved stool consistency; Lactobacillus casei shirota; Probiotic

Indexed keywords

MONOCLONAL ANTIBODY; PROBIOTIC AGENT;

ADULT; AGED; ARTICLE; BACTERIAL SURVIVAL; CONSTIPATION; CONTROLLED STUDY; DEFECATION; DEFECATION HABIT; DIGESTIVE TRACT PARAMETERS; DOUBLE BLIND PROCEDURE; ENZYME LINKED IMMUNOSORBENT ASSAY; FECES; FECES ANALYSIS; FERMENTED PRODUCT; HARD FECES; HUMAN; INTESTINE FLORA; LACTOBACILLUS CASEI; LACTOBACILLUS CASEI SHIROTA; MAJOR CLINICAL STUDY; MILK; NONHUMAN; RANDOMIZED CONTROLLED TRIAL; STOOL CONSISTENCY;

EID: 84905665131     PISSN: 15551431     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Chmielewska, A. and Szajewska, H. (2010). Systematic review of randomised controlled trials: probiotics for functional constipation. World Journal of Gastroenterology 16:69-75.
2. Cummings, J.H., Antoine, J.M., Azpiroz, F., Bourdet-Sicard, R., Brandtzaeg, P., Calder, P., Gibson, G.R., Guarner, F., Isolauri, E., Pannemans, D., Shortt, C., Tuijtelaars, S. and Watzl, B. (2004). PASSCLAIM - Gut health and immunity. European Journal of Nutrition suppl 21 43, II/118-II/173.
3. De Preter, V., Geboes, K., Verbrugghe, K., De Vuyst, L., Vanhoutte, T., Huys, G., Swings, J., Pot, B. and Verbeke, K. (2004). The in vivo use of the stable isotope-labelled biomarkers lactose - [15N]ureide and [2H4]tyrosine to assess the effects of pro- and pre-biotics on the intestinal flora of healthy human volunteers. British Journal of Nutrition 92:439-446.
4. De Preter, V., Raemen, H., Cloetens, L., Houben, E., Tutgeerts, P. and Verbeke K. (2008). Effect of dietary intervention with different pre- and probiotics on intestinal bacterial enzyme activities. European Journal of Clinical Nutrition 62 :225-31.
5. De Preter, V., Vanhoutte, T., Huys, G., Swings, J., De Vuyst, L., Rutgeerts, P. and Verbeke, K. (2007). Effects of Lactobacillus casei Shirota, Bifidobacterium breve, and oligofructose-enriched inulin on colonic nitrogen-protein metabolism in healthy humans. American Journal of Physiology and Gastrointestinal Liver Physiology 292:G358-68.
6. FAO/WHO (2001) Joint FAO/WHO Expert Consultation on evaluation of health and nutritional properties of probiotics in food including powder milk with live lactic acid bacteria. Cordoba, Argentina, October 2001. http://www.who.int/ foodsafety/publications/fs-management/en/probiotics.pdf
7. Gibson, G.R., Rouzaud, G., Brostoff, J. and Rayment, N. (2005). An evaluation of probiotic effects in the human gut: microbial aspects. Final Technical report for FSA project ref G01022. http://www.food.gov.uk/multimedia/ pdfs/probioticreport.pdf
8. Heaton, K.W., Radvan, J., Cripps, H., Mountford, R.A., Braddon, F.E. and Hughes, A.O. (1992). Defecation frequency and timing, and stool form in the general population: A prospective study. Gut 33:818-24.
9. Hickson, M. (2013). Examining the evidence for the use of probiotics in clinical practice. Nursing Standard 27:35-41.
10. Hungin, A.P., Mulligan, C., Pot, B., Whorwell, P., Agréus, L., Fracasso, P., Lionis, C., Mendive, J., Philippart de Foy, J.M., Rubin, G., Winchester, C., de Wit, N. and the European Society for Primary Care Gastroenterology (2013). Systematic review: probiotics in the management of lower gastrointestinal symptoms in clinical practice - an evidence-based international guide. Alimentary Pharmacology and Therapeutics [Epub ahead of print].
11. ILSI Europe (2013) ILSI Europe Concise Monograph on probiotics, prebiotics and the gut microbiota, 1st Edition. ILSI Europe, Brussels. http://www.ilsi.org/Europe/Publications/Prebiotics-Probiotics.pdf
12. Koebnick, C., Wagner, I., Leitzmann, P., Stern, U. and Zunft H.J. (2003). Probiotic beverage containing Lactobacillus casei Shirota improves gastrointestinal symptoms in patients with chronic constipation. Canadian Journal of Gastroenterology 17:655-9.
13. Krammer, H.-J., von Seggern, H., Schaumburg, J. and Neumer, F. (2011) Effect of Lactobacillus casei Shirota on colonic transit time in patients with chronic constipation. Coloproctology 33:109-113.
14. Levin, R. (2011) Probiotics - the road map. International Journal of Probiotics & Prebiotics 6:133-140.
15. Lewis, S.J. and Heaton, K.W. (1997). Stool form scale as a useful guide to intestinal transit time. Scandinavian Journal of Gastroenterology 32: 920-924.
16. Longstreth, G.F., Thompson, W.G., Chey, W.D., Houghton, L.A., Mearin, F. and Spiller, R.C. (2006). Functional bowel disorders. Gastroenterology 130:1480-91.
17. Lupp, S., Skipper, M. and Weiss, U. (2012). Gut microbes and health. Nature Insight 489, 219.
18. Matsumoto, K., Takada, T., Shimizu, K., Kado, Y., Kawakami, K., Makino, I., Yamaaoka, Y., Hirano, K., Nomoto, K., Nishimura, A. and Kajimoto, O. (2006). The effect of a probiotic milk product containing Lactobacillus casei strain Shirota on the defecation frequency and the intestinal microfolora of sub-optimal health state volunteers: a randomized placebo-controlled cross-over study. Bioscience Microflora 25:39-48.
19. Mcmanus, C.M., Michel, K.E, Simon, D.M. and Washabau, R.J. (2002). Effect of short-chain fatty acids on contraction of smooth muscle in the canine colon. American Journal of Veterinarian Research 63:295-300.
20. Mitsuoka, T. (1990) Bifidobacteria and their role in human health.. Journal of Industrial Microbiology 6,263-8.
21. Picard, C., Fioramonti, J., Francois, A., Robinson, T., Neant, F. and Matuchansky C. Review article: bifidobacteria as probiotic agents-physiological effects. (2005). Alimentary and Pharmacological Therapy 22,495-512.
22. Raj, K. and Hirano, I. (1996) The Enteric Nervous System. The New England Journal of Medicine 334: 1106-15.
23. Sakai, T., Makino, H., Ishikawa, E., Oishi, K. and Kushiro, A. (2011) Fermented milk containing Lactobacillus casei strain Shirota reduces incidence of hard or lumpy stools in healthy population. International Journal of Food Sciences and Nutrition 62(4):23-30.
24. Sanders, M.E., Guarner, F., Guerrant, R., Holt, P.R., Quigley, E.M., Sartor, R.B., Sherman, P.M. and Mayer, E.A. (2013). An update on the use and investigation of probiotics in health and disease. Gut 62:787-96.
25. Shanahan, F. (2010). Gut microbes: from bugs to drugs. American Journal of Gastroenterology 105: 275-9.
26. Si, J.M., Yu, Y.C., Fan, Y.J. and Chen, S.J. (2004). Intestinal microecology and quality of life in irritable bowel syndrome patients. World Journal of Gastroenterology 10:1802-05.
27. Spanhaak, S., Havenaar, R. and Schaafsma, G. (1998). The effect of consumption of milk fermented by Lactobacillus casei strain Shirota on the intestinal microflora and immune parameters in humans. European Journal of Clinical Nutrition 52:899-283.
28. Talley, N.J. (1999). Irritable bowel syndrome ; definition, diagnosis, and epidemiology. Baillieres Best Practices in Research on Clinical Gastroenterology 13:371-84.
29. Tuohy, K.M., Pinart-Gilberga, M., Jones, M., Hoyles, L., McCartney, A.L. and Gibson, G.R. (2007). Survivability of a probiotic Lactobacillus casei in the gastrointestinal tract of healthy human volunteers and its impact on the faecal microflora. Journal of Applied Microbiology 102: 1026-32.
30. West, N.P., Pyne, D.B., Peake, J.M. and Cripps, A.W. (2009). Probiotics, immunity and exercise: a review. Exercise Immunology Reviews 15: 107-26.
31. Whelan, K. and Quigley, E.M. (2013). Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. Current opinion in gastroenterology 29(2):184-9.
32. World Gastroenterology Organisation (2011). Practice guideline: probiotics and prebiotics, October 2011. http://www.worldgastroenterology.org/ probiotics-prebiotics
33. Yajima, T. (1984). Effect of sodium propionate on the contractile response of the rat ileum in situ. Japanese Journal of Pharmacology. 35:265-71.
34. Yokokura, T., Yajima, T. and Hashimoto, S. (1977). Effect of organic acid on gastrointestinal motility of rat in vitro. Life Science 21:59-62.
35. Yuki, N., Watanabe, K., Mike, A., Tagami, Y., Tanaka, R., Ohwaki, M. and Morotomi M. (1999). Survival of a probiotic, Lactobacillus casei strain Shirota, in the gastrointestinal tract: selective isolation from faeces and identification using monoclonal antibodies. International Journal of Food Microbiology 48:51-57.